Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis
- 1 February 2016
- journal article
- Published by Elsevier in Life Sciences
- Vol. 146, 100-108
Abstract
No abstract availableKeywords
Funding Information
- SK Telecom Research Fund (34-2014-0230)
- National Research Foundation of Korea (NRF-2015R1A2A2A04002733)
This publication has 33 references indexed in Scilit:
- Intestinal homeostasis and its breakdown in inflammatory bowel diseaseNature, 2011
- Beneficial health effects of lupeol triterpene: A review of preclinical studiesLife Sciences, 2011
- Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤8 mm) nephrolithiasisUrology Annals, 2011
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulationHepatology, 2010
- Dietary phenethylisothiocyanate attenuates bowel inflammation in miceBMC Chemical Biology, 2010
- Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpeneCancer Letters, 2009
- Ursolic acid: An anti‐ and pro‐inflammatory triterpenoidMolecular Nutrition & Food Research, 2008
- Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitisBritish Journal of Pharmacology, 2007
- Suppression of T lymphocyte activity by lupeol isolated fromCrataeva religiosaPhytotherapy Research, 2006
- Ursolic acid enhances nitric oxide and tumor necrosis factor‐α production via nuclear factor‐κB activation in the resting macrophagesFEBS Letters, 2001